CO2 Solutions Inc. — Investor Relations & Filings
Filings indexed
286
across all filing types
Latest filing
2019-10-17
Regulatory Filings
Country
CA
Canada
Listing
TSXV
CST
CO2 Solutions Inc. is an innovator specializing in the development and commercialization of proprietary, enzyme-enabled technologies for the capture and production of carbon dioxide (CO2). The company's core offering is a patented enzymatic process designed to provide a low-cost alternative to conventional carbon capture methods. This technology is actively being validated at pilot scale for industrial applications, including efficient carbon capture from high-volume sources such as oil sands operations. The firm focuses on solving the technical and economic challenges associated with large-scale CO2 mitigation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2019-10-17 | English | |
| News release - French.pdf | 2019-09-17 | English | |
| News release - English.pdf | 2019-07-02 | English | |
| News release - French.pdf | 2019-05-29 | English | |
| Interim MD&A - English.pdf | 2019-05-29 | English | |
| 52-109FV2 - Certification of interim filings - CEO (F).pdf | 2019-05-29 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2019
14 filings
| |||||
| 47115963 | News release - English.pdf | 2019-10-17 | English | ||
| 47115967 | News release - French.pdf | 2019-09-17 | English | ||
| 47115978 | News release - English.pdf | 2019-07-02 | English | ||
| 47115982 | News release - French.pdf | 2019-05-29 | English | ||
| 47115985 | Interim MD&A - English.pdf | 2019-05-29 | English | ||
| 47116017 | 52-109FV2 - Certification of interim filings - CEO (F).pdf | 2019-05-29 | English | ||
| 47116040 | News release - French.pdf | 2019-04-29 | English | ||
| 47116043 | News release - French.pdf | 2019-04-01 | English | ||
| 47116049 | News release - French.pdf | 2019-03-14 | English | ||
| 47116073 | News release - English.pdf | 2019-02-28 | English | ||
| 47116083 | News release - French.pdf | 2019-02-28 | English | ||
| 47116086 | Interim financial statements/report – French.pdf | 2019-02-28 | English | ||
| 47116113 | Interim MD&A - French.pdf | 2019-02-28 | English | ||
| 47116259 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2019-02-28 | English | ||
|
2018
1 filing
| |||||
| 47116267 | News release - English.pdf | 2018-12-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Repare Therapeutics Inc.
A clinical-stage oncology company developing targeted cance…
|
RPTX | US | Professional, scientific and te… |
|
Replimune Group, Inc.
A clinical-stage biotech developing oncolytic immunotherapi…
|
REPL | US | Professional, scientific and te… |
|
ReproCELL Incorporated
Provider of stem cell technology and services for research …
|
4978 | JP | Professional, scientific and te… |
|
RESEARCH FRONTIERS INC
Develops and licenses patented light-control technology for…
|
REFR | US | Professional, scientific and te… |
|
RESONANCE HEALTH LIMITED
Develops non-invasive MRI software for quantitative analysi…
|
RHT | AU | Professional, scientific and te… |
|
Respiratorius AB
A research company developing innovative drug candidates, p…
|
RESP | SE | Professional, scientific and te… |
|
REVELATION BIOSCIENCES, INC.
Clinical-stage biopharma developing immunologic therapies t…
|
REVB | US | Professional, scientific and te… |
|
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Clinical-stage biopharma developing therapeutics for CNS, r…
|
RVPH | US | Professional, scientific and te… |
|
Revolution Medicines, Inc.
Clinical-stage precision oncology company developing therap…
|
RVMD | US | Professional, scientific and te… |
|
R&G PharmaStudies Co., Ltd.
Full-service CRO providing clinical research solutions for …
|
301333 | CN | Professional, scientific and te… |
CO2 Solutions Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45191/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45191 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45191 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45191 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45191}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CO2 Solutions Inc. (id: 45191)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.